Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines

The Food and Drug Administration (FDA) has announced a forecasted funding opportunity titled "Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines" under opportunity number FOR-FD-25-010. This grant is intended to support the development and dissemination of clinical practice guidelines, with a particular focus on those previously developed with FDA support. The cooperative agreement will enable the selected recipient to create and implement a comprehensive strategy for distributing these guidelines, ensuring their widespread adoption, with an emphasis on equity in healthcare delivery. The purpose of this funding is to enhance the reach and impact of clinical practice guidelines, which are essential for improving the quality of healthcare and patient outcomes. Effective dissemination strategies are necessary to ensure that healthcare providers across different regions, including underserved communities, can access and utilize these guidelines. The grant will fund activities related to creating educational and promotional materials, evaluating dissemination methods, and using innovative channels to increase awareness and use of the guidelines in clinical practice. A significant aspect of the program is to ensure equity, ensuring that the dissemination plan addresses disparities in healthcare access and outcomes. The FDA expects to make one award under this opportunity, with total program funding set at $1,000,000. The award ceiling and floor are both fixed at $1,000,000, meaning the recipient will receive the full amount to execute the project. This financial support will enable the recipient to develop an effective dissemination plan, covering all necessary activities from evaluation to the creation and distribution of materials that promote the use of clinical guidelines. Eligible applicants for this cooperative agreement include a wide range of entities such as state, county, and local governments, public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (excluding small businesses), independent school districts, and Native American tribal organizations and governments. This broad eligibility criterion allows many different types of organizations to apply, particularly those with experience in healthcare, public health, or guideline dissemination. Applicants are required to propose a comprehensive plan to ensure effective dissemination. The plan should outline strategies for reaching diverse healthcare providers and ensuring the guidelines are used in a way that improves health equity. Priority will be given to approaches that address barriers to access, especially in under-resourced or underserved communities. The application and award dates have not yet been confirmed, but applicants should monitor for further updates closer to the estimated post date in late 2024. For additional details, applicants can reach out to the FDA's grantor contact, Terrin Brown, at (240) 402-7610 or via email at terrin.brown@fda.hhs.gov. This funding represents a valuable opportunity for organizations committed to improving healthcare practices through the effective dissemination of clinical guidelines and ensuring that these guidelines reach all corners of the healthcare system, particularly where they are most needed.